Stockholders Equity | NOTE 6 STOCKHOLDERS’ EQUITY On March 4, 2015, the Company with the consent of the Majority Shareholder and Unanimous Written Consent of the Board of Directors created and authorized the issuance of Series A Convertible Preferred stock, with a par value of $0.00001 per share. The face amount of state value of each Preferred Share of stock is $0.96. On June 24, 2015, the Company with the consent of the Majority Shareholder and Unanimous Written Consent of the Board of Directors filed with the State of Delaware an Amended Certificate of Incorporation increasing the authorized shares of common stock by 120,000,000 shares of common stock from 450,000,000 million shares of common stock to 570,000,000 shares of common stock. On August 19, 2015, the Company with the consent of the Majority Shareholder and Unanimous Written Consent of the Board of Directors filed with the State of Delaware an Amended Certificate of Incorporation increasing the authorized shares of common stock by 280,000,000 shares of com mon stock from 570,000,000 million shares of common stock to 850,000,000 shares of common stock. On January 13, 2016, the Company with the consent of the Majority Shareholder and Unanimous Written Consent of the Board of Directors filed with the Securities and Exchange Commission a Schedule 14C and with the State of Delaware an Amended Certificate of Incorporation increasing the authorized shares of common stock by 800,000,000 shares of common stock from 850,000,000 million shares of common stock to 1,650,000,000 shares of common stock. (A) Common Stock During the year ended December 31, 2015, the Company issued the following common stock: Transaction Type Quantity Valuation Range of Value per share Conversion of convertible debt and accrued interest 154,673,471 $ 2,918,633 $0.009 - $0.042 Services - rendered 9,195,182 390,624 $0.12-$0.07 Return of shares (120,000,000 ) (1,200) $ 0.000010 Conversion of line of credit in common stock 5,000,000 148,500 $ 0.03 Total shares issued 48,868,653 $ 3,361,981 During the year ended December 31, 2014, the Company issued the following common stock: Transaction Type Quantity Valuation Range of Value per share Conversion of convertible debt and accrued interest 48,998,342 $ 3,421,019 $ $0.02715 - $0.14175 Services - rendered 3,150,000 678,030 $ 0.093-$0.365 Acquisition of intangibles 15,000,000 1,514,000 $ 0.0985-0.12 Return of shares (4,250,000 ) — $ — Settlement of accounts payable 1,000,000 900,000 $ 0.09 Total shares issued 63,898,342 $ 5,703,049 The following is a detailed description of transactions noted above: 1. Conversion of convertible debt and accrued interest During the year ended December 31, 2015, the Co During the year ended December 31, 2014, the Company converted debt and accrued interest, totaling $3,421,019 into 48,998,342 shares of common stock. Conversions of debt to equity occurring after the maturity date and penalties incurred resulted in a loss on settlement of $183,911. 2. Services Rendered During the year ended December 31, 2015, the Company issued 200,000 shares of common stock having a fair value of $14,000 ($0.070/sh.) in exchange for consulting services. During the year ended December 31, 2015, the Company issued 200,000 shares of common stock having a fair value of $10,000 ($0.050/sh.) in exchange for consulting services. During the year ended December 31, 2015, the Company issued 2,246,858 shares of common stock having a fair value of $53,925 ($0.012/sh.) in exchange for consulting services. During the year ended December 31, 2015, the Company issued 200,000 shares of common stock having a fair value of $8,000 ($0.040/sh.) in exchange for consulting services. On December 21, 2015, the Company issued 100,000 shares of common stock having a fair value of $2,000 ($0.020/sh.) in exchange for consulting services. On November 23, 2015, the Company issued 200,000 shares of common stock having a fair value of $6,000 ($0.030/sh.) in exchange for consulting services. On September l1, 2015, the Company issued 1,000,000 shares of common stock to employee having a fair value of $23,800 ($0.024/sh.) in exchange for services. On September 10, 2015, the Company issued 2,048,324 shares of common stock having a fair value of $62,679($0.031/sh.) in exchange for legal services of 138,433. This resulted in a gain on settlement of $75,954. On May 4, 2015, the Company issued 200,000 shares of common stock having a fair value of $10,700 ($0.054/sh) in exchange for consulting services. On April 1, 2015, the Company issued 150,000 shares of common stock having a fair value of $4,455 ($0.0284/sh) in exchange for consulting services. On April 1, 2015, the Company issued 150,000 shares of common stock having a fair value of $4,455 ($0.0284/sh) in exchange for consulting services. On April 1, 2015, the Company issued 300,000 shares of common stock having a fair value of $8,910 ($0.0284/sh) in exchange for consulting services. On March 1, 2015, the Company issued 375,000 shares of common stock to employees having a fair value of $20,725 ($0.040 – 0.063) in exchange for services. On February 28, 2015, the Company entered into a services agreement. In connection with this agreement, the consultant will receive 700,000 shares of fully vested common stock. During the year ended December 31, 2014, the Company issued 1,250,000 shares of common stock valued at $386,250 in connection with employment agreements entered into (See Note 9 (A). On January 15, 2013, the Company entered into an agreement for legal services, pursuant to which the Company will pay $2,000 and issue 50,000 shares of fully vested common stock for the preparation, filing costs and fees of each provisional and regular patent application. Through December 31, 2014, a total of 44 applications have been filed. In connection with this agreement: During the year ended December 31, 2014, the Company issued 800,000 shares of fully vested common stock for services having a fair value of $131,500 ($0.11 - $0.168/share). On March 17, 2014, the Company entered into an advisory board agreement for a period of three years. In consideration for these services, during the year ended December 31, 2014, the Consultant was granted 100,000 shares of fully vested common stock valued at $9,300 ($0.09/share). (See note 7(B)). On April 4, 2014, the Company entered into consulting services agreement. In consideration for these services, during the year ended December 31, 2014, the Consultant was granted 200,000 shares of fully vested common stock valued at $21,980 ($0.11/share). (See note 7(B)). During the year ended December 31, 2014, the Company entered into a consulting services agreement related to marketing and the creation of Company awareness. In connection with this agreement, the consultant shall be paid $20,000 and was issued 200,000 fully vested shares of common stock valued at $31,000 ($0.16/share). (See note 7(B)). On August 6, 2014, the Company entered into an advisory board agreement for a period of three years. In consideration for these services, during the year ended December 31, 2014, the Consultant was granted 100,000 fully vested shares of common stock valued at $16,500 ($0.17/share). (See note 7(B)). On September 23, 2014, the Company entered into service agreement for a period of two years with the Company’s transfer agent. In consideration for these services, during the year ended December 31, 2014, 300,000 shares of fully vested common stock valued at $49,500 ($0.17/share) were granted and expensed. On September 10, 2014, the Company entered into an advisory board agreement. In consideration for these services, during the year ended December 31, 2014, the Consultant was granted 100,000 shares of fully vested common stock valued at $16,000 ($0.16/share). (See note 7(B)). On July 29, 2014, the Company entered into an investor relations agreement. In connection with this agreement, the Company is to issue 100,000 shares of common stock monthly and $5,500 in monthly fees. As of December 31, 2014, the agreement was terminated. In total, the consultant was issued 100,000 shares of fully vested common stock valued at $16,000 ($0.16/share) and was paid $5,500. (See note 7(B)). 3. Return of Shares and Issuance of Preferred shares On March 4, 2015 the Company filed a form 8K with the SEC associated with the Company entering into a Securities Exchange Agreement and the Company filing with the Secretary of State Delaware a Certificate of Designations, Preferences and Rights whereby, among other things, the Company for good and valuable consideration, agreed that in consideration of a large shareholder exchanging 120,000,000 shares of common stock back to the Company, the shareholder would receive 5,000,000 shares of Series A Convertible Preferred Stock of the Company at a Stated Value of $0.96 per share and a Conversion Price of $0.04 per share. The Series A Convertible Preferred Stock carries certain voting preferences and will accrue dividends at a rate of 8% per annum Stated Value, payable in cash or in kind at the election of the Board of Directors. For the year ended December 31, 2015, the Company has not declared dividends. 4. Conversion of line of credit into Common shares On April 1, 2015, the principal stockholder converted $150,000 of the line of credit owed into 5,000,000 shares of common stock at $0.03 per share. During the year December 31, 2014, the Company issued 15,000,000 common shares in connection with license agreements entered into and intangibles acquired. See Note 1(I) 6. Settlement of accounts payable During the year ended December 31, 2014, the Company settled accounts payable totaling $154,320 through the issuance of 1,000,000 common shares with a valuation of $90,000. The Company recognizes a gain on settlement of $64,320. (B) Stock Warrants On October 7, 2015, the Company issued 1,000,000 warrants in connection with the entry into certain convertible debenture agreements. Warrant vests immediately and expires on October 7, 2018 with an exercise price of $0.12. On October 26, 2015, the Company issued 1,000,000 warrants in connection with the entry into certain convertible debenture agreements. Warrant vests immediately and expires on October 26, 2018 with an exercise price of $0.12. During the year ended December 31, 2014, the Company issued 750,000 warrants in connection with the entry into certain convertible debenture agreements. Each warrant vests immediately and expire February 26, 2017 – August 12, 2017 with an exercise price of $0.40. The following tables summ arize all warrant grants as of December 31, 2015 and 2014, and the related changes during these periods are presented below: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2013 3,135,000 $ 0.25 2.2 Granted 950,000 $ 0.34 Exercised — $ — Cancelled/Forfeited (335,000 ) $ 0.10 Balance, December 31, 2014 3,750,000 $ 0.25 1.7 Granted 2,000,000 $ — Exercised — $ — Cancelled/Forfeited (200,000 ) $ — Balance, December 31, 2015 5,550,000 $ 0.25 1.5 A summary of all outstanding and exercisable warrants as of December 31, 2015 is as follows: Weighted Average Exercise Warrants Warrants Remaining Aggregate Price Outstanding Exercisable Contractual Life Intrinsic Value $ 0.10 200,000 200,000 1.90 $ — $ 0.12 2,000,000 2,000,000 2.77 $ — $ 0.40 2,850,000 2,850,000 0.73 $ — $ 0.45 500,000 500,000 — $ — 5,550,000 5,550,000 1.5 years $ — A summary of all outstanding and exercisable warrants as of December 31, 2014 is as follows: Exercise Price Warrants Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.10 200,000 200,000 2.90 $ — $ 0.25 200,000 200,000 0.44 $ — $ 0.40 2,850,000 2,850,000 1.73 $ — $ 0.45 500,000 500,000 1.00 $ — 3,750,000 3,750,000 1.7 years $ — (C) Stock Options The following tables summarize all option grants as of December 31, 2015, and the related changes during these periods are presented below: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding - December 31, 2013 12,700,000 0 2 Granted 2,866,652 $ 0.10 3.00 Exercised — — — Forfeited or Canceled — — — Outstanding - December 31, 2014 15,566,652 0.13 1.32 Granted — — — Exercised — — — Forfeited or Canceled — — — Outstanding - December 31, 2015 15,566,652 0.13 0.32 Exercisable - December 31, 2015 15,566,652 |